The UK stock market is hitting new all-time highs in 2026, yet plenty of discounted stocks remain available for investors willing to dig deeper into the market.
Pets at Home (LSE: PETS) has recently caught the attention of value-focused investors looking for both share price recovery potential and a growing passive income stream.
The business has faced tremendous pressure in recent years, with management forced to slash its dividend nearly in half, cutting the payout from 13p per share down to just 7.4p.
At first glance, that kind of dividend reduction does not exactly signal a screaming buy opportunity for income-seeking investors.
However, beneath the surface of all that turbulence, some intriguing green shoots have begun to emerge that could signal an important inflexion point ahead.
As one of the largest pet and vet store chains in the United Kingdom, Pets at Home once appeared to enjoy a powerful, almost monopoly-like market position that many investors found deeply attractive.
On the retail side, an increasingly tough economic environment has pushed many pet owners to trade down to cheaper, lower-margin products, squeezing profitability considerably.
The group’s latest results made the retail damage clear, with consumer revenue falling 1% and retail underlying pre-tax profit slumping 57.8% to just £30.8m.
The company’s vet division, by contrast, delivered a much more encouraging performance, with sales rising 5% and underlying earnings climbing 10%, moving from £75.9m to £83.8m.
Overall earnings were still down almost 30%, yet the share price actually rose on the back of these results, suggesting investors may already be looking beyond the near-term pain.
A significant overhang for the business had been a regulatory investigation launched by the Competition and Markets Authority, which understandably spooked many shareholders and weighed heavily on sentiment.
That investigation has now concluded, and while it has forced Pets at Home to alter certain practices, the actual impact appears to be considerably less severe than many investors had feared.
Adding a structural tailwind to the picture, a large wave of pets adopted during the pandemic are now entering the second half of their lifespans, a period typically associated with higher health and care spending.
Management is also actively working to repair its retail proposition, with price cuts already helping to drive higher volumes and improve customer satisfaction scores, even if near-term margins face further pressure.
Following the recent dividend cut, Pets at Home now offers a yield of 3.8%, which is modest but holds meaningful recovery potential if the vet business continues to scale and the retail arm stabilises.
If management can successfully use its retail stores as a customer onboarding tool while growing the higher-margin vet division, earnings and dividends could both rebound more strongly over time.
Significant execution and strategic risks remain, but with early signs of improvement beginning to appear in the numbers and regulatory uncertainty now lifted, those risks may be worth weighing carefully.
